Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.680
-0.160 (-4.17%)
Aug 1, 2025, 4:00 PM - Market closed
Perspective Therapeutics Market Cap
Perspective Therapeutics has a market cap or net worth of $273.16 million as of August 1, 2025. Its market cap has decreased by -65.18% in one year.
Market Cap
273.16M
Enterprise Value
66.76M
1-Year Change
-65.18%
Ranking
Category
Stock Price
$3.68
Market Cap Chart
Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $273.16M, an increase of 448.51%. That is a compound annual growth rate of 9.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 285.00M | 32.19% |
Dec 31, 2024 | 215.60M | 91.13% |
Dec 29, 2023 | 112.80M | 221.37% |
Dec 30, 2022 | 35.10M | -36.18% |
Dec 31, 2021 | 55.00M | 39.95% |
Dec 31, 2020 | 39.30M | -6.65% |
Dec 31, 2019 | 42.10M | 108.42% |
Dec 31, 2018 | 20.20M | -8.18% |
Dec 29, 2017 | 22.00M | -31.03% |
Dec 30, 2016 | 31.90M | -38.18% |
Dec 31, 2015 | 51.60M | -35.58% |
Dec 31, 2014 | 80.10M | 317.19% |
Dec 31, 2013 | 19.20M | -28.89% |
Dec 31, 2012 | 27.00M | 41.36% |
Dec 30, 2011 | 19.10M | -28.20% |
Dec 31, 2010 | 26.60M | 30.39% |
Dec 31, 2009 | 20.40M | 343.48% |
Dec 31, 2008 | 4.60M | -90.09% |
Dec 31, 2007 | 46.40M | -40.28% |
Dec 29, 2006 | 77.70M | 9.75% |
Dec 30, 2005 | 70.80M | 42.17% |
Nov 10, 2005 | 49.80M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 664.39B |
Johnson & Johnson | 396.75B |
AbbVie | 333.89B |
AstraZeneca | 232.21B |
UnitedHealth Group | 226.39B |
Novartis AG | 224.47B |
Abbott Laboratories | 219.63B |
Novo Nordisk | 213.92B |